Advisory Panel Shows Support for OTC HIV Test, Highlights Community Need
This article was originally published in The Tan Sheet
Executive Summary
Over-the-counter availability of a rapid HIV test would provide a public health benefit, members of FDA's Blood Products Advisory Committee generally agreed at a Nov. 3 meeting in Gaithersburg, Md
You may also be interested in...
OraSure Plans To File Over-The-Counter HIV Test Application By Year End
OraSure Technologies says it expects this year to complete a pre-market application for its OraQuick Advance Rapid HIV-1 and -2 over-the-counter saliva test. The product would be the first HIV diagnostic intended for use at home and providing results directly to the user.
OraSure Plans To File Over-The-Counter HIV Test Application By Year End
OraSure Technologies says it expects this year to complete a pre-market application for its OraQuick Advance Rapid HIV-1 and -2 over-the-counter saliva test. The product would be the first HIV diagnostic intended for use at home and providing results directly to the user.
OraSure Plans To File Over-The-Counter HIV Test Application By Year End
OraSure Technologies says it expects this year to complete a pre-market application for its OraQuick Advance Rapid HIV-1 and -2 over-the-counter saliva test. The product would be the first HIV diagnostic intended for use at home and providing results directly to the user.